21![I am writing to request an opportunity to make a formal oral presentation at the Pediatric Advisory Committee meeting on Febru I am writing to request an opportunity to make a formal oral presentation at the Pediatric Advisory Committee meeting on Febru](https://www.pdfsearch.io/img/355079702f9453ba84aa05501c5f35fb.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-03-02 16:59:00
|
---|
22![Pediatric Advisory Committee Topical Immunosuppressants Inhibit DNA Repair Daniel B. Yarosh, Ph.D. AGI Dermatics Freeport, NY Pediatric Advisory Committee Topical Immunosuppressants Inhibit DNA Repair Daniel B. Yarosh, Ph.D. AGI Dermatics Freeport, NY](https://www.pdfsearch.io/img/049a4164df8c2485af79632f4cf2a3c7.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-03-02 17:24:41
|
---|
23![I graduated from nursing school and specialized in pediatric nursing I graduated from nursing school and specialized in pediatric nursing](https://www.pdfsearch.io/img/09f8097dbc30ee107d61e752d18ed713.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-03-02 16:59:01
|
---|
24![Vincent S. Beltrani, MD, FAAAAI Board Certified by American Academy of Dermatology American Academy Allergy, Asthma & Immunology Associate Clinical Professor Vincent S. Beltrani, MD, FAAAAI Board Certified by American Academy of Dermatology American Academy Allergy, Asthma & Immunology Associate Clinical Professor](https://www.pdfsearch.io/img/ecec75afccad002e9de110556efca9d8.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-03-02 17:24:44
|
---|
25![Macrolides / Type 1 hypersensitivity / Autoimmune diseases / Tacrolimus / Atopic dermatitis / Pimecrolimus / Eczema / Atopy / Topical steroid / Medicine / Lymphoma / Immunosuppressants Macrolides / Type 1 hypersensitivity / Autoimmune diseases / Tacrolimus / Atopic dermatitis / Pimecrolimus / Eczema / Atopy / Topical steroid / Medicine / Lymphoma / Immunosuppressants](/pdf-icon.png) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-02-11 16:14:06
|
---|
26![Background Package Fujisawa Healthcare, Inc. Pediatric Advisory Committee Food and Drug Administration Background Package Fujisawa Healthcare, Inc. Pediatric Advisory Committee Food and Drug Administration](https://www.pdfsearch.io/img/8b98229e290db60674009e58cfea61f5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-02-11 16:14:06
|
---|
27![DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville, MD[removed]DATE: DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville, MD[removed]DATE:](https://www.pdfsearch.io/img/70df8b2352fa1422c2f20b33b22404b1.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-02-11 16:14:03
|
---|
28![Novartis Pharmaceuticals Corporation/Novartis Pharma AG East Hanover, New Jersey/Basel, Switzerland Drug Regulatory Affairs Elidel (pimecrolimus) Cream 1% Novartis Pharmaceuticals Corporation/Novartis Pharma AG East Hanover, New Jersey/Basel, Switzerland Drug Regulatory Affairs Elidel (pimecrolimus) Cream 1%](https://www.pdfsearch.io/img/0bf809bd2f879f5f394adf064de67555.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-02-11 16:15:24
|
---|
29![Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed] Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]](https://www.pdfsearch.io/img/211b2eb7212456b7aa9bfad446e6b224.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2013-01-01 09:43:51
|
---|
30![Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed] Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]](https://www.pdfsearch.io/img/b6314f9ed58dccef8fa00453c2175161.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2013-01-01 09:43:51
|
---|